| Literature DB >> 34755456 |
Da Woon Lee1, Heongrae Ryu1, Hwan Jun Choi1,2, Nam Hun Heo3.
Abstract
Necrotising fasciitis (NF) is a rapidly progressing fatal disease. Craniofacial necrotising fasciitis (CNF) is limited to the region above the mandibular margin, and early diagnosis is particularly difficult in the absence of related studies. Ten-year data of patients with craniofacial infection were collected from four separate hospitals. Based on the diagnostic criteria, patients were classified into abscess and CNF. The risk factors for early diagnosis were analysed by comparing the two groups. Simple abscess was found in 176 patients, and CNF was detected in 25 patients. The risk factors associated with CNF include old age, presence of odontogenic infection, elevated white blood cell count (WBC), increased C-reactive protein (CRP), high levels of creatinine (Cr) and glucose (Glu) and low levels of haemoglobin (Hb) and albumin (Alb). In addition, fever above 38°C and sinusitis at the time of admission and progressive sepsis after admission were also risk factors. Among the statistically significant risk factors, low Alb level showed the greatest association with CNF progression. Appropriate management of CNF via early diagnosis and extensive surgical intervention based on identified risk factors can reduce the mortality rate, complications and unnecessary medical expenses. Clinical question/level of evidence: Diagnostic, III.Entities:
Keywords: craniofacial; early diagnosis; multi-centre; necrotising fasciitis; risk factor
Mesh:
Year: 2021 PMID: 34755456 PMCID: PMC9284621 DOI: 10.1111/iwj.13703
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.099
Laboratory risk indicator for necrotising fasciitis (LRINEC) score system
| CRP (mg/dL) | <15 | 0 |
| ≥15 | 4 | |
| WBC (per mm3) | <15 | 0 |
| 15–25 | 1 | |
| >25 | 2 | |
| Haemoglobin (g/dL) | >13.5 | 0 |
| 11 to 13.5 | 1 | |
| <11 | 2 | |
| Sodium (mEq/L) | ≥135 | 0 |
| <135 | 2 | |
| Creatinine (mg/dL) | ≤1.6 | 0 |
| >1.6 | 2 | |
| Glucose (mg/dL) | ≤180 | 0 |
| >180 | 1 | |
| Composite Score | Score< 6 | Low risk |
| Score 6 to 7 | Intermediate | |
| Score≥ 8 | High risk |
Abbreviations: CRP, C‐reactive protein; WBC, white blood cell.
FIGURE 1Photographic images of craniofacial necrotising fasciitis (CNF) in a 79‐year‐old woman because of odontogenic infection. (A) Severe swelling and induration were observed throughout in the right cheek. (B) Transient facial palsy as a result of swelling and compression of the buccal branch of the facial nerve was observed on the 5th day of post‐operative days (POD) after surgical decompression. (C) On the 31st day of POD after surgical decompression, trismus was observed, but swelling and transient facial palsy improved
FIGURE 2Craniofacial necrotising fasciitis (CNF) in a 58‐year‐old man because of unknown origin. (A) Axial computed tomography (CT) shows multiple soft‐tissue abscess with air bubbles (white arrow), (B) At enhanced phase, axial CT shows polymorphic wall enhancing lesions in the muscle (white arrow), (C). CT image of POD 25, more decreased size of abscess formation in left masseter and temporalis muscle
FIGURE 3Craniofacial necrotising fasciitis (CNF) in an 89‐year‐old woman infected through the raw surface of the right maxilla 3 days after tooth extraction. (A) Necrotising fasciitis with multiple abscess pockets along the temporalis muscle (red arrow indicates the lesion site). (B) Findings of necrotising fasciitis spreading through the right perimandibular area and deep temporal fascia
FIGURE 4Flow diagram for selection of the craniofacial necrotising fasciitis (CNF) patient population
Demographic characteristics between CNF and simple abscess groups
| Characteristic | Total (n = 201) | CNF |
| |
|---|---|---|---|---|
| CNF (n = 25) | abscess (n = 176) | |||
| Old age | ||||
| ≥65 | 47 (23.4) | 14 (56.0) | 33 (18.8) | <.001 |
| <65 | 154 (76.6) | 11 (44.0) | 143 (81.3) | |
| Sex | ||||
| Male | 99 (49.3) | 12 (48.0) | 87 (49.4) | >.99 |
| Female | 102 (50.7) | 13 (52.0) | 89 (50.6) | |
| Infection route | ||||
| Unknown | 139 (69.2) | 13 (52.0) | 126 (71.6) | .017 |
| Skin trauma | 36 (17.9) | 4 (16.0) | 32 (18.2) | |
| Odontogenic infection | 26 (12.9) | 8 (32.0) | 18 (10.2) | |
| Culture bacteria | ||||
| Gram positive | 71 (35.5) | 7 (28.0) | 64 (36.6) | .096 |
| Gram negative | 24 (12.0) | 6 (24.0) | 18 (10.3) | |
| polymicrobial | 3 (1.5) | 1 (4.0) | 2 (1.1) | |
| no growth | 54 (27.0) | 8 (32.0) | 46 (26.3) | |
| No culture test | 48 (24.0) | 3 (12.0) | 45 (25.7) | |
| MRSA | ||||
| Identified | 14 (7.0) | 1 (4.0) | 13 (7.4) | >.99 |
| Non‐identified | 187 (93.0) | 24 (96.0) | 163 (92.6) | |
| Antibiotics | ||||
| Empirical antibiotics | 120 (59.7) | 8 (32.0) | 112 (63.6) | .005 |
| Broad spectrum antibiotics | 81 (40.3) | 17 (68.0) | 64 (36.4) | |
| Medical past history | ||||
| Diabetes mellitus | 35 (17.4) | 7 (28.0) | 28 (15.9) | .158 |
| Solid organ cancer | 5 (2.5) | 2 (8.0) | 3 (1.7) | .118 |
| Liver cirrhosis | 1 (0.5) | — | 1 (0.6) | >.99 |
| Surgical procedure period after onset | ||||
| ≤5 days | 31 (15.4) | 4 (16.0) | 27 (15.3) | .665 |
| >5 days | 113 (56.2) | 16 (64.0) | 97 (55.1) | |
| none | 57 (28.4) | 5 (20.0) | 52 (29.5) | |
Abbreviations: CNF, craniofacial necrotising fasciitis; MRSA, methicillin‐resistant Staphylococcus aureus.
FIGURE 5Photographic images of craniofacial necrotising fasciitis (CNF) in a 43‐year‐old man. (A) Severe swelling and induration were observed throughout the left cheek. (B) 6 months after surgical decompression, the patient recovered successfully without trismus
Treatments and outcomes in craniofacial necrotising fasciitis (CNF) patients
| Patient | Age | Sex | Infection route | LRINEC score | Albumin (g/dL) | Days to surgical decompression | Number of surgical decompressions | Method of wound healing | Death |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 56 | M | Unknown | 0 | 4.2 | 5 days | 1 | Secondary healing | No |
| 2 | 58 | M | Unknown | 5 | 2.9 | 5 days | 1 | Secondary healing | No |
| 3 | 76 | M | Unknown | 2 | 3.3 | 3 days | 1 | Secondary healing | No |
| 4 | 46 | F | Skin trauma | 0 | 3.4 | No operation | 0 | Secondary healing | No |
| 5 | 78 | F | Unknown | 2 | 3.2 | 7 days | 11 | Secondary healing | No |
| 6 | 82 | M | Unknown | 1 | 3.3 | 5 days | 1 | Local flap | No |
| 7 | 89 | F | Odontogenic infection | 6 | 2.0 | 9 days | 8 | Secondary healing | No |
| 8 | 81 | F | Unknown | 4 | 2.3 | No operation | 0 | FTSG | No |
| 9 | 43 | M | Unknown | 6 | 3.3 | 8 days | 1 | Secondary healing | No |
| 10 | 75 | M | Odontogenic infection | 3 | 4.5 | 10 days | 1 | FTSG, STSG | No |
| 11 | 47 | M | Odontogenic infection | 5 | 3.5 | 10 days | 1 | Secondary healing | No |
| 12 | 77 | M | Unknown | 2 | 3.2 | 20 days | 1 | Local flap | No |
| 13 | 86 | F | Skin trauma | 3 | 2.5 | No operation | 0 | Secondary healing | No |
| 14 | 60 | M | Odontogenic infection | 8 | 2.9 | 9 days | 1 | FTSG | No |
| 15 | 46 | F | Unknown | 5 | 2.2 | No operation | 0 | Secondary healing | No |
| 16 | 79 | F | Odontogenic infection | 5 | 3.0 | 9 days | 1 | Local flap | No |
| 17 | 61 | F | Unknown | 3 | 3.5 | 8 days | 1 | Secondary healing | No |
| 18 | 76 | F | Skin trauma | 5 | 2.5 | 7 days | 1 | STSG | No |
| 19 | 79 | M | Unknown | 11 | 2.6 | 10 days | 1 | Secondary healing | No |
| 20 | 39 | M | Unknown | 3 | 2.7 | 7 days | 11 | FTSG | No |
| 21 | 69 | M | Skin trauma | 3 | 2.8 | 28 days | 1 | Local flap | No |
| 22 | 60 | F | Odontogenic infection | 7 | 4.1 | No operation | 0 | Secondary healing | No |
| 23 | 83 | M | Odontogenic infection | 10 | 2.3 | 5 days | 1 | Secondary healing | No |
| 24 | 77 | F | Unknown | 7 | 2.7 | 7 days | 3 | Secondary healing | No |
| 25 | 46 | M | Odontogenic infection | 7 | 2.7 | 3 days | 2 | Secondary healing | No |
Abbreviations: CNF, craniofacial necrotising fasciitis; FTSG, full‐thickness skin graft; LRINEC, laboratory risk indicator for necrotising fasciitis; STSG, split‐thickness skin graft.
Comparison of risk factors of craniofacial necrotising fasciitis (CNF) and simple abscess
| Total (n = 201) | CNF |
| ||
|---|---|---|---|---|
| NF (n = 25) | Abscess (n = 176) | |||
| WBC (10 000/μL) | 10 000.0 (7890.0‐13 885.0) | 14 590.0 (9245.0‐17 500.0) | 9500.0 (7840.0‐12 910.0) | .011 |
| ≤10 000 | 100 (49.8) | 6 (24.0) | 94 (53.4) | |
| >10 000 | 101 (50.2) | 19 (76.0) | 82 (46.6) | |
| Crp (5.0 mg/L) | 17.2 (3.0‐55.0) | 65.0 (17.5‐186.9) | 14.2 (2.8‐41.6) | .011 |
| ≤5 | 65 (32.3) | 2 (8.0) | 63 (35.8) | |
| >5 | 136 (67.7) | 23 (92.0) | 113 (64.2) | |
| Sodium (136 mmol/L) | 140.0 (139.0‐142.0) | 138.0 (135.0‐142.0) | 140.0 (139.0‐142.0) | .003 |
| >135 | 180 (90.9) | 18 (72.0) | 162 (93.6) | |
| ≤135 | 18 (9.1) | 7 (28.0) | 11 (6.4) | |
| Creatinine (>1.5 mg/dL) | 0.8 (0.6‐1.0) | 0.9 (0.7‐1.3) | 0.8 (0.6‐1.0) | .005 |
| ≤1.5 | 194 (96.5) | 21 (84.0) | 173 (98.3) | |
| >1.5 | 7 (3.5) | 4 (16.0) | 3 (1.7) | |
| Glucose (>110 mg/dL) | 116.0 (102.0‐154.8) | 147.0 (126.0‐180.0) | 113.0 (100.0‐149.0) | .010 |
| ≤110 | 75 (37.3) | 3 (12.0) | 72 (40.9) | |
| >110 | 127 (62.7) | 22 (88.0) | 104 (59.1) | |
| Albumin (3.0 g/dL) | 3.79 ± 0.6 | 3.02 ± 0.53 | 3.9 ± 0.52 | <.001 |
| ≤3.0 | 22 (11.0) | 14 (56.0) | 8 (4.6) | |
| >3.0 | 179 (89.0) | 11 (44.0) | 168 (95.4) | |
| Hb (<13 g/dL) | 12.1 (11.0‐13.6) | 10.9 (9.9‐11.7) | 12.3 (11.3‐13.8) | .005 |
| >13 | 71 (35.3) | 2 (8.0) | 69 (39.2) | |
| ≤13 | 130 (64.7) | 23 (92.0) | 107 (60.8) | |
| LRINEC score | 2.0 (1.0‐2.8) | 5.0 (2.5‐6.5) | 1.0 (1.0‐2.0) | <.001 |
| LRINEC score risk | ||||
| Low risk | 185 (92.0) | 17 (68.0) | 168 (95.5) | <.001 |
| Intermediate risk | 11 (5.5) | 5 (20.0) | 6 (3.4) | |
| High risk | 5 (2.5) | 3 (12.0) | 2 (1.1) | |
| Sepsis | ||||
| Appearance | 31 (15.4) | 13 (52.0) | 18 (10.2) | <.001 |
| Non‐appearance | 170 (84.6) | 12 (48.0) | 158 (89.8) | |
| Septic shock | ||||
| Non‐appearance | 2 (1.0) | 1 (4.0) | 1 (0.6) | .234 |
| Appearance | 199 (99.0) | 24 (96.0) | 175 (99.4) | |
| Fever | ||||
| ≥38 | 40 (19.9) | 12 (48.0) | 28 (15.9) | <.001 |
| <38 | 161 (80.1) | 13 (52.0) | 148 (84.1) | |
| BMI | ||||
| ≥23 | 85 (42.5) | 12 (50.0) | 73 (41.5) | .747 |
| <23 | 110 (55.0) | 12 (50.0) | 98 (55.7) | |
| unknown | 5 (2.5) | — | 5 (2.8) | |
| Dental procedure | ||||
| Appearance | 18 (9.0) | 5 (20.0) | 13 (7.4) | .055 |
| Non‐appearance | 183 (91.0) | 20 (80.0) | 163 (92.6) | |
| Sinusitis | ||||
| Appearance | 22 (10.9) | 8 (32.0) | 14 (8.0) | .002 |
| Non‐appearance | 179 (89.1) | 17 (68.0) | 162 (92.0) | |
Abbreviations: BMI, body mass index; CRP, C‐reactive protein; CNF, craniofacial necrotising fasciitis; Hb, haemoglobin; LRINEC, laboratory risk indicator for necrotising fasciitis; WBC, white blood cell.
FIGURE 6Receiver operating characteristic (ROC) curve based on laboratory risk factors. The area under the curve for low albumin is the highest at 0.757
Significance and odd ratio values of each variable through logistic regression analysis. Low albumin has the highest correlation with craniofacial necrotising fasciitis (CNF) and other risk factors
| Univariable logistic analysis | Multivariable logistic analysis | |||
|---|---|---|---|---|
| OR |
| OR |
| |
| Old age | ||||
| ≥65 | Ref | Ref. | ||
| <65 | 0.181 (0.076‐0.435) | <.001 | 0.305 (0.063‐1.481) | .141 |
| Sex | ||||
| Male | Ref. | |||
| Female | 1.059 (0.458–2.449) | .893 | ||
| Infection route | ||||
| Unknown | Ref. | Ref. | ||
| Skin trauma | 1.212 (0.370‐3.966) | .751 | 0.385 (0.049‐3.037) | .365 |
| Odontogenic infection | 4.308 (1.569‐11.824) | .005 | 9.546 (1.693‐53.824) | .011 |
| Culture bacteria | ||||
| Gram positive | Ref. | |||
| Gram negative | 3.048 (0.909‐10.213) | .071 | ||
| Polymicrobial | 4.571 (0.366‐57.049) | .238 | ||
| No growth | 1.590 (0.539‐4.695) | .401 | ||
| No culture test | 0.596 (0.146‐2.429) | .471 | ||
| MRSA | ||||
| Appearance | Ref. | |||
| Non‐appearance | 1.914 (0.240‐15.300) | .540 | ||
| Antibiotics | ||||
| Empirical antibiotics | Ref. | Ref. | ||
| Broad spectrum antibiotics | 3.719 (1.520‐9.098) | .004 | 2.996 (0.732‐12.273) | .127 |
| Medical past history | ||||
| Diabetes mellitus | 2.056 (0.786‐5.379) | .142 | ||
| Solid organ cancer | 5.015 (0.795‐31.616) | .086 | ||
| Surgical procedure period after onset | ||||
| ≤5 days | Ref. | |||
| >5 days | 1.113 (0.344‐3.608) | .858 | ||
| None | 0.649 (0.161‐2.618) | .544 | ||
| WBC (10 000/μL) | ||||
| ≤10 000 | Ref. | Ref. | ||
| >10 000 | 3.468 (1.322‐9.097) | .012 | 6.817 (1.319‐35.242) | .022 |
| CRP (5.0 mg/L) | ||||
| ≤5 | Ref. | |||
| >5 | 7.069 (1.615‐30.947) | .009 | ||
| Sodium (136 mmol/L) | ||||
| >135 | Ref. | |||
| ≤135 | 5.727 (1.974‐16.621) | .001 | ||
| Creatinine (>1.5 mg/dL) | ||||
| ≤1.5 | Ref. | |||
| >1.5 | 3.889 (1.412‐10.710) | .009 | ||
| Glucose (>110 mg/dL) | ||||
| ≤110 | Ref. | Ref. | ||
| >110 | 4.959 (1.431‐17.188) | .012 | 4.644 (0.624‐34.543) | .134 |
| Albumin (3.0 g/dL) | ||||
| ≤3.0 | 24.691 (8.826‐68.966) | <.001 | 17.794 (3.893‐81.301) | <.001 |
| >3.0 | Ref. | Ref. | ||
| Hb (<13 g/dL) | ||||
| >13 | Ref. | |||
| ≤13 | 7.416 (1.695‐32.456) | .008 | ||
| LRINEC score risk | ||||
| Low risk | Ref. | |||
| Intermediate risk | 8.235 (2.273‐29.839) | .001 | ||
| High risk | 14.824 (2.314‐94.978) | .004 | ||
| Antibiotic period | ||||
| <14 days | ref. | Ref. | ||
| ≥14 days | 0.116 (0.047‐0.286) | <.001 | 0.228 (0.050‐1.038) | .056 |
| Sepsis | ||||
| Appearance | Ref. | Ref. | ||
| Non‐appearance | 0.105 (0.042‐0.265) | <.001 | 0.254 (0.045‐1.443) | .122 |
| Septic shock | ||||
| Non‐appearance | Ref. | |||
| Appearance | 0.137 (0.008‐2.265) | .165 | ||
| ICU admission | ||||
| Appearance | Ref. | |||
| Non‐appearance | 0.137 (0.008‐2.265) | .165 | ||
| Fever | ||||
| ≥38 | Ref. | |||
| <38 | 0.205 (0.085‐0.495) | <.001 | ||
| BMI | ||||
| ≥23 | Ref. | |||
| <23 | 0.745 (0.317‐1.753) | .500 | ||
| Dental procedure | ||||
| Appearance | Ref. | |||
| Non‐appearance | 0.319 (0.103‐0.989) | .048 | ||
| Sinusitis | ||||
| Appearance | Ref. | Ref. | ||
| Non‐appearance | 0.184 (0.067‐0.500) | <.001 | 0.111 (0.021‐0.602) | .011 |
Abbreviations: BMI, body mass index; CRP, C‐reactive protein; Hb, haemoglobin; ICU, intensice care unit; LRINEC, Laboratory Risk Indicator for Necrotising Fasciitis; MRSA, methicillin‐resistant Staphylococcus aureus; WBC, white blood cell.
‘Ref.’ is the reference standard value for statistical analysis.
Extensive literature search reviews on craniofacial necrotising fasciitis (CNF)
| References | Patients (N) | Age | Conclusion |
|---|---|---|---|
| Thomas AJ et al | 17 | Average: 45.5 | The utilisation of LRINEC scores and white blood cell counts and sodium levels is not useful for differentiating cervical NF from non‐NF infections. Because there are many non‐specific clinical courses, clinicians must maintain vigilance. |
| Thakur JS et al | 38 | 10 months to 82 years, Average: 55 | The most important factor in determining prognosis was the time interval between the onset of CNF and surgical intervention. |
| Kovacić M et al | 15 | Average: 54 | Mention the importance of early diagnosis and appropriate surgical intervention, broad‐spectrum antibiotics and intravenous immunoglobulin therapy. |
| Zhao Y et al | 29 | Unknown | Early surgical intervention is useful in reducing complications. |
| Nougué H et al | 160 |
33 to 64 years Median: 50 | Evidence of the usefulness of CT scan and partial efficacy of prehospital oral glucocorticoid intake. |
| Sandner A et al | 16 | Average: 57 | Patients with a LRINEC score ≥ 6 should be carefully evaluated for progression of CNF. |
| Juncar M et al | 55 |
17 to 78 years Average: 41 | Odontogenic infection is the most common cause, explaining the importance of early diagnosis and aggressive surgical procedures. |
| Elander J et al | 59 |
17 to 89 years Average: 60 | The utilisation of combination therapy with hyperbaric oxygen therapy and early surgical debridement can reduce mortality in patients with cervical NF. |
| Gahleitner C et al | 10 |
42 to 85 years Average: 64 | Patients with acute tonsillitis with age >35 years and serum CRP >15.5 mg/dL with retropharyngeal abscess have a high association with NF. |
| Hernandez DA et al | 29 | 19 to 81 years | A collection of existing 24 case reports, which should be sufficiently suspected and boldly diagnosed at an early stage. |
| Gore, M. R. | 164 |
15 to 83 years Average: 44 |
A collection of existing 58 case reports. Anaemia, diabetes mellitus and malnutrition were the major systemic condition coexisting in CNF. |
| Gunaratne DA et al | 969 | Average: 49.14 | CNF may have subtle early clinical findings and requires active intervention to prevent fatal local and systemic morbidity and mortality. |
| Ogawa et al | 26 |
22 to 88 years Average: 62 | CRP, WBC, Cr and skin flare in the cervical and precordial areas were extracted as independent factors. Introduced LRINEC‐OC with some improvements to the LRINEC Score system. |
| Sideris G et al | 11 | 17 to 62 years | It was found that the presence or absence of immunosuppression was not related to the development of CNF. |
| Melis A et al | 11 |
9 to 87 years Average: 41 | Correct clinical diagnosis and early medical and surgical treatment were crucial in reducing complications; LRNEC score, C‐reactive protein, glycaemia and creatininaemia has proven to be a reliable prognostic indicator. |
| Fiorella ML et al | 118 |
2 to 83 years Average: 48 | LRINEC and NLR (neutrophil to lymphocyte ratio) scores are useful for rapidly predicting the risk of necrotising fasciitis and systemic involvement at an early diagnostic stage. |
| Sideris G et al | 12 | Unknown | LRINEC score, using 6 as a cutoff, proves to be a useful ‘rule‐out’ tool, and among the items, CRP and Glu seem to be the most significant variables. Diagnosis of NF must be based on medical history, clinical symptoms and signs, imaging findings and laboratory tests and not according to the LRINEC score itself. |
| Sizer B et al | 16 | 19 to 71 years | Odontogenic infection is the most common cause, and the risk is increased in diabetic patients and broad‐spectrum antibiotics should be initiated when infection is suspected. |
Abbreviation: CNF, craniofacial necrotising fasciitis; CRP, C‐reactive protein; CT, computed tomography.